Dinutuximab beta (1) – Dinutuximab beta EUSA®
Other antineoplastic agents
Characteristics
| Start date | 08.09.2017 |
|---|---|
| Resolution | 19.10.2017 |
| INN | Dinutuximab beta |
| Brand name | Dinutuximab beta EUSA® |
| Pharm. company | EUSA Pharma (Germany) GmbH |
| G-BA Procedure ID | F-004 |
| ATC code | L01FX06 Other monoclonal antibodies and antibody drug conjugates (L01FX) |
| DDD | 2.6 mg P |
| Therapeutic area | Oncological diseases Neuroblastoma Orphan |
| Reason for procedure | not completed: exempted |
Associated procedures
<< List of all resolutions